Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Roche (Belgium) | Researchclopedia

Back to institutions

Roche (Belgium)

Brusselscompany

114

Works

23,959

Citations

87

h-index

Top Research Topics

Asthma and respiratory diseases Immune Response and Inflammation Monoclonal and Polyclonal Antibodies Research

Top Researchers

José Baselga Hebron University

1,379 works117,695 citationsh-index: 143

Recent Research

Inter-Satellite Link Network Real-Time Ring Dissemination Performance and Robustness

Enrico Edoardo Zini,Christina Wagner,et al.

20260 citations

Regulation of Appetite and Obesity

Biochemical Analysis and Sensing Techniques

Immune Cell Function and Interaction

Cancer Genomics and Diagnostics

HER2/EGFR in Cancer Research

Cytokine Signaling Pathways and Interactions

Breast Cancer Treatment Studies

Glycosylation and Glycoproteins Research

Phase Change Materials Research

Martine Piccart Université Libre de Bruxelles

1,550 works114,743 citationsh-index: 149

Martin J. van den Bent St James's University Hospital

1,352 works99,999 citationsh-index: 128

1,511 works95,028 citationsh-index: 131

Denis Lacombe European Organisation for Research and Treatment of Cancer

165 works65,917 citationsh-index: 43

Matti Aapro Clinique de Genolier

865 works42,977 citationsh-index: 103

P58 An Evaluation Framework for Healthcare Professionals’ Digital Health and AI Technologies: Evidence-Based Policy Recommendations

Afua van Haasteren,Paola Botrugno,et al.

20250 citations

EPH95 The Role of Adjuvant Atezolizumab in Reducing Recurrence-Related Treatment Costs in Resected Early-Stage PD-L1 High Non-Small Cell Lung Cancer in Belgium

L Herteleer,M Arnold,et al.

20240 citations

EE501 Cost-Effectiveness Analysis (CEA) of Pertuzumab and Trastuzumab (PH) + Chemotherapy (CT) Versus H + CT in HER2-Positive Early Breast Cancer (EBC): Updated Model Using Data From the 8.4-Year Follow-up of APHINITY

SA Kommandantvold,MJ Schlögel,et al.

20240 citations

pionERA Breast Cancer (BC): Phase III study of first-line (1L) giredestrant vs. fulvestrant, both combined with a cyclin-dependent kinase 4/6 inhibitor (CDK4/6i), in patients (pts) with estrogen receptor-positive (ER+), HER2– locally advanced/metastatic BC (LA/mBC) with resistance to prior adjuvant (adj) endocrine therapy (ET).

Kevin Kalinsky,Rinath Jeselsohn,et al.

20240 citations

Understanding breast cancer (BC) from the patient (pt) perspective: A qualitative study of symptoms, impacts and health-related quality of life (HRQoL) in hormone receptor-positive, HER2-negative (HR+, HER2–) BC.

Bruno Kovic,Anna Steenrod,et al.

20240 citations